EGI
SRDX

EAM Global Investors’s Surmodics SRDX Stock Holding History

EAM Global Investors’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,281
Closed -$769K – 155
2018
Q4 		$769K Sell
16,281
-3,534
-18% -$212K 0.42% 115
2018
Q3 		$1.48M Sell
19,815
-2,505
-11% -$173K 0.6% 72
2018
Q2 		$1.23M Sell
22,320
-13,899
-38% -$642K 0.6% 86
2018
Q1 		$1.38M Buy
+36,219
New +$1.12M 0.71% 38

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

EAM Global Investors's SRDX Position: Q1 2019 in Review

EAM Global Investors sold out of Surmodics (SRDX) in Q1 2019, closing a stake of 16,281 shares — an estimated $769K sold.

EAM Global Investors first reported a position in SRDX in Q1 2018 and held it in 4 quarters. The position peaked at $1.48M in Q3 2018. 151 funds tracked by Wall St. Rank hold SRDX as of Q1 2019.

  • EAM Global Investors reported no remaining Surmodics position as of Q1 2019 after selling out during the quarter.
  • EAM Global Investors sold 16,281 Surmodics shares in Q1 2019, an estimated $769K.
  • EAM Global Investors first reported a position in Surmodics in Q1 2018 and held it in 4 quarters.
  • EAM Global Investors's Surmodics position peaked at $1.48M in Q3 2018.
  • 151 funds tracked by Wall St. Rank held Surmodics as of Q1 2019.

Based on EAM Global Investors's 13F filing for Q1 2019, filed 10 May 2019.